Finance

Lists
SANA:NASDAQ
Sana Biotechnology Inc
US$ २.०२
+०.५०%
(+०.०१००) 1D
नोभेम्बर १३, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SANA...
Open
US$ २.०५
High
US$ २.०५
Low
US$ १.८६
Mkt. cap
६०.५३ करोड
Avg. vol.
३०.३१ लाख
Volume
३२.०१ लाख
52-wk high
US$ ५.४९
52-wk low
US$ १.८६
EPS
-US$ ०.५३
Beta
२.३०
Shares outstanding
२९.९६ करोड
No. of employees
१४२
Open
US$ २.०५
High
US$ २.०५
Low
US$ १.८६
Mkt. cap
६०.५३ करोड
Avg. vol.
३०.३१ लाख
Volume
३२.०१ लाख
52-wk high
US$ ५.४९
52-wk low
US$ १.८६
EPS
-US$ ०.५३
Beta
२.३०
Shares outstanding
२९.९६ करोड
No. of employees
१४२
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
३ घण्टा पहिले
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
About Sana Biotechnology Inc
CEOSteve Harr
Employees१४२
Founded२०१८
Headquartersसिएटल, वासिङ्टन डी.सी., संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitesana.com
Analyst ratings
Based on 4 analysts giving stock ratings to SANA in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for SANA in the last 3 months.
Highest
Current US$ २.०२
US$ १२.०० (+४९४.०६%)
Average
US$ ८.०० (+२९६.०४%)
Lowest
US$ ६.०० (+१९७.०३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alec Stranahan
Bank of America Securities
Buy
Reiterated
US$ ६.००
+१९७%
11/06/2026
Martin Fan
Wedbush
Buy
Maintained
US$ ७.००
+२४६.५%
11/06/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$ ७.००
+२४६.५%
09/21/2026
Maxwell Skor
Morgan Stanley
Buy
Reiterated
US$ १२.००
+४९४.१%
08/17/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
08/11/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ १६.००
+६९२.१%
05/11/2026
Samantha Semenkow
Citi
Buy
Maintained
US$ १२.००
+४९४.१%
03/04/2026
Last report
२०२६ नोभेम्बर ५
Fiscal period
Q3 2026
-US$ ०.१४ / -US$ ०.१३
-४.८६%miss
Revenue / Est. (USD)
- / ०.००
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
४.०४ करोड
२.६४ करोड
३.८३ करोड
२.६० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.२२ करोड
१.१५ करोड
१.०८ करोड
१.०९ करोड
Operating expense
५.२६ करोड
३.७९ करोड
४.९१ करोड
३.७० करोड
Total operating expenses
५.२६ करोड
३.७९ करोड
४.९१ करोड
३.७० करोड
Operating income
-५.२६ करोड
-३.७९ करोड
-४.९१ करोड
-३.७० करोड
Other non operating income
३३.९८ लाख
४.५३ लाख
६.५६ लाख
६.७६ लाख
EBT including unusual items
-५.८८ करोड
-४.७२ करोड
-६.३६ करोड
२.०४ करोड
EBT excluding unusual items
-४.७९ करोड
-३.६५ करोड
-४.७३ करोड
-३.५१ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-५.८८ करोड
-४.७२ करोड
-६.३६ करोड
२.०४ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.१६
-०.१४
-०.१३
-०.१४
Interest and investment income
१२.७६ लाख
९.५१ लाख
११.२९ लाख
१२.१९ लाख
Interest expense
-
-
-
-
Net interest expenses
१२.७६ लाख
९.५१ लाख
११.२९ लाख
१२.१९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.९६ करोड
-३.५५ करोड
-४.६८ करोड
-३.४० करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू